Conference · London, United Kingdom
Targeted Antibodies for Cancer (TAC)
Health · Medicine · Pharmaceuticals
Key numbers
- Editions on record
- 1first in 2011
About Targeted Antibodies for Cancer (TAC)
TAC2011 will address the critical scientific issues and challenges associated with developing targeted therapeutic antibodies for cancer. It will highlight improvements in antibody development, global trends and current clinical progress.
Benefits of attending TAC 2011:
• Hear about the latest trends in antibody therapeutics for cancer: antibodies to watch in 2011 and the future
• Join in with the discussion about what biosimilars will mean for the pharma industry
• Understand the best strategies for improving antibody production
• Receive practical advice about taking antibodies from concept to reality with instructive case studies highlighting successful new antibodies in development
• Examine how to capture the potential of personalised antibody therapies for cancer
• Assess bispecific, trifunctional, radiolabelled antibodies and antibody-drug conjugates in the treatment of cancer
• Network with leading experts in the field and build up your business prospects
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2011 | 16–17 Nov 2011 | etc venues Paddington London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Targeted Antibodies for Cancer (TAC)?
The next dates haven't been confirmed. The last edition we have on record was 16–17 Nov 2011.
Where is it held?
The last edition we have was at etc venues Paddington, London, United Kingdom.